Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
While CRISPR-Cas9 enables precise targeting of cancer-driving genetic aberrations, its clinical application is impeded by instability, delivery inefficiencies, and immunogenicity. Nanotechnology addresses these challenges by engineering nanocarriers that facilitate enhanced cellular uptake, promote...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2026-03-01
|
| Серія: | Journal of Nanotheranostics |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2624-845X/7/1/6 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|